Display options
Cite
Head BM, Trajtman A, Rueda ZV, et al. Atypical bacterial pneumonia in the HIV-infected population. Pneumonia (Nathan). 2017;9:12doi: 10.1186/s41479-017-0036-z.
Head, B. M., Trajtman, A., Rueda, Z. V., Vélez, L., & Keynan, Y. (2017). Atypical bacterial pneumonia in the HIV-infected population. Pneumonia (Nathan Qld.), 912. https://doi.org/10.1186/s41479-017-0036-z
Head, Breanne M, et al. "Atypical bacterial pneumonia in the HIV-infected population." Pneumonia (Nathan Qld.) vol. 9 (2017): 12. doi: https://doi.org/10.1186/s41479-017-0036-z
Head BM, Trajtman A, Rueda ZV, Vélez L, Keynan Y. Atypical bacterial pneumonia in the HIV-infected population. Pneumonia (Nathan). 2017 Aug 25;9:12. doi: 10.1186/s41479-017-0036-z. eCollection 2017. PMID: 28856082; PMCID: PMC5571654.
Copy Download .nbib Format: NLM
Share it on

Pneumonia (Nathan). 2017 Aug 25;9:12. doi: 10.1186/s41479-017-0036-z. eCollection 2017.

Atypical bacterial pneumonia in the HIV-infected population.

Pneumonia (Nathan Qld.)

Breanne M Head, Adriana Trajtman, Zulma V Rueda, Lázaro Vélez, Yoav Keynan

Affiliations

  1. Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  2. Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin, Colombia.
  3. Grupo Investigador de Problemas en Enfermedades Infecciosas, Universidad de Antioquia UdeA, Medellin, Colombia.
  4. Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
  5. Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

PMID: 28856082 PMCID: PMC5571654 DOI: 10.1186/s41479-017-0036-z

Abstract

Human immunodeficiency virus (HIV)-infected individuals are more susceptible to respiratory tract infections by other infectious agents (viruses, bacteria, parasites, and fungi) as their disease progresses to acquired immunodeficiency syndrome. Despite effective antiretroviral therapy, bacterial pneumonia (the most frequently occurring HIV-associated pulmonary illness) remains a common cause of morbidity and mortality in the HIV-infected population. Over the last few decades, studies have looked at the role of atypical bacterial pneumonia (i.e. pneumonia that causes an atypical clinical presentation or responds differently to typical therapeutics) in association with HIV infection. Due to the lack of available diagnostic strategies, the lack of consideration, and the declining immunity of the patient, HIV co-infections with atypical bacteria are currently believed to be underreported. Thus, following an extensive database search, this review aimed to highlight the current knowledge and gaps regarding atypical bacterial pneumonia in HIV. The authors discuss the prevalence of

Keywords: Atypical; Bacteria; Chlamydophila; Coxiella; HIV; Legionella; Mycoplasma; Pneumonia; Tropheryma

References

  1. Clin Infect Dis. 1996 Jul;23(1):107-13 - PubMed
  2. Int J Infect Dis. 2007 May;11(3):232-8 - PubMed
  3. Clin Infect Dis. 1999 Apr;28(4):866-72 - PubMed
  4. J Infect. 2012 Sep;65(3):275-8 - PubMed
  5. JAMA. 1983 Oct 21;250(15):1981-5 - PubMed
  6. Pediatr Infect Dis J. 1992 Nov;11(11):972-3 - PubMed
  7. Microbes Infect. 2010 Dec;12(14-15):1102-10 - PubMed
  8. Curr Opin Infect Dis. 2015 Apr;28(2):185-92 - PubMed
  9. Clin Infect Dis. 2011 May;52 Suppl 4:S296-304 - PubMed
  10. Clin Infect Dis. 1998 Jan;26(1):14-9 - PubMed
  11. Clin Microbiol Rev. 1995 Oct;8(4):451-61 - PubMed
  12. Clin Infect Dis. 1994 Feb;18(2):227-32 - PubMed
  13. Public Health Rep. 2017 Mar/Apr;132(2):241-250 - PubMed
  14. Clin Infect Dis. 1998 Jul;27(1):97-9 - PubMed
  15. Infect Drug Resist. 2010;3:73-86 - PubMed
  16. J Clin Microbiol. 2012 Dec;50(12):3917-20 - PubMed
  17. Cell Immunol. 1996 May 25;170(1):127-33 - PubMed
  18. Diagn Microbiol Infect Dis. 2016 Jul;85(3):295-301 - PubMed
  19. Lancet. 1996 Aug 3;348(9023):307-12 - PubMed
  20. Chest. 2003 Aug;124(2):543-7 - PubMed
  21. Clin Infect Dis. 1995 Sep;21(3):712-3 - PubMed
  22. J Natl Med Assoc. 2001 Jun;93(6):220-3 - PubMed
  23. Am J Respir Crit Care Med. 2000 Dec;162(6):2063-8 - PubMed
  24. Infection. 1990 Nov-Dec;18(6):342-6 - PubMed
  25. Clin Microbiol Rev. 2004 Oct;17(4):697-728, table of contents - PubMed
  26. Curr Opin Infect Dis. 2001 Apr;14(2):181-6 - PubMed
  27. Emerg Infect Dis. 2004 Mar;10(3):501-4 - PubMed
  28. Clin Microbiol Infect. 2004 Sep;10(9):820-5 - PubMed
  29. Thorax. 1993 Dec;48(12):1261-3 - PubMed
  30. Medicine (Baltimore). 2017 Jan;96(4):e5778 - PubMed
  31. Arch Intern Med. 1994 Nov 14;154(21):2417-22 - PubMed
  32. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 - PubMed
  33. Proc Am Thorac Soc. 2011 Jun;8(3):282-7 - PubMed
  34. Clin Infect Dis. 1992 Jan;14(1):178-82 - PubMed
  35. Lancet. 2015 Sep 12;386(9998):1097-108 - PubMed
  36. AIDS. 1996 Nov;10(13):1543-7 - PubMed
  37. Eur Respir J. 2012 Mar;39(3):730-45 - PubMed
  38. J Negat Results Biomed. 2016 Mar 02;15:3 - PubMed
  39. Am J Respir Crit Care Med. 2013 May 15;187(10):1110-7 - PubMed
  40. Clin Infect Dis. 1993 Jun;16(6):741-7 - PubMed
  41. AIDS. 1993 Jan;7(1):81-6 - PubMed
  42. J Infect. 2006 Nov;53(5):325-30 - PubMed
  43. Front Microbiol. 2016 Jun 22;7:974 - PubMed
  44. AIDS Patient Care STDS. 2008 Jun;22(6):473-81 - PubMed
  45. J Med Microbiol. 2006 Jun;55(Pt 6):759-63 - PubMed
  46. Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10 ):720-6 - PubMed
  47. Medicine (Baltimore). 1989 Mar;68(2):116-32 - PubMed
  48. N Engl J Med. 2006 Oct 5;355(14):1503-5 - PubMed
  49. Indian J Pediatr. 2011 Apr;78(4):430-4 - PubMed
  50. New Microbes New Infect. 2013 Oct;1(1):6-12 - PubMed
  51. Lancet Infect Dis. 2014 Oct;14(10):1011-21 - PubMed
  52. J Clin Microbiol. 1985 Dec;22(6):1055 - PubMed
  53. Diagn Microbiol Infect Dis. 2004 Oct;50(2):141-5 - PubMed
  54. J Infect Dis. 2002 Jul 1;186(1):127-8 - PubMed
  55. Int J STD AIDS. 2012 Apr;23(4):287-8 - PubMed
  56. Int J Epidemiol. 2002 Oct;31(5):1001-7 - PubMed
  57. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):612-6 - PubMed
  58. Clin Infect Dis. 2003 Dec 1;37(11):1475-80 - PubMed
  59. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4 - PubMed
  60. J Infect. 2002 Oct;45(3):199-201 - PubMed
  61. Semin Respir Crit Care Med. 2016 Dec;37(6):876-885 - PubMed
  62. J Infect Chemother. 2013 Jun;19(3):538-41 - PubMed
  63. J Acquir Immune Defic Syndr. 2001 May 1;27(1):35-43 - PubMed
  64. Clin Infect Dis. 2008 Sep 1;47(5):659-67 - PubMed
  65. J Clin Microbiol. 2002 Jan;40(1):165-71 - PubMed
  66. Chest. 1998 May;113(5):1195-200 - PubMed
  67. BMC Infect Dis. 2012 Sep 22;12 :225 - PubMed
  68. J Med Microbiol. 1990 Dec;33(4):253-8 - PubMed
  69. Scand J Infect Dis. 2007;39(2):122-8 - PubMed
  70. Clin Microbiol Infect. 2009 Dec;15 Suppl 2:140-1 - PubMed
  71. Antimicrob Agents Chemother. 1999 Jan;43(1):90-5 - PubMed
  72. Clin Infect Dis. 2013 Aug;57(4):485-8 - PubMed
  73. Nat Rev Immunol. 2010 Jan;10(1):11-23 - PubMed
  74. HIV Med. 2005 Jan;6(1):27-32 - PubMed
  75. Vaccine. 2010 Feb 17;28(7):1677-83 - PubMed
  76. Clin Infect Dis. 1995 Feb;20(2):329-34 - PubMed
  77. Lancet Infect Dis. 2016 Mar;16(3):e13-22 - PubMed
  78. Emerg Infect Dis. 2016 Jan;22(1):131-3 - PubMed
  79. Curr Infect Dis Rep. 2007 May;9(3):228-32 - PubMed
  80. J Clin Microbiol. 2013 Jan;51(1):348-51 - PubMed

Publication Types